check this out, page-22

cpg,
the statement I highlighted in my 'article', was
"Biota also announced that patient enrolment of the key Phase III studies in Asia had now been completed with results expected to be released mid year."

I thought I made it pretty clear, but to sumamrise.
Biota said enrollment was complete, dosing was five days. Last patient complete is trial complete, ergo the trial was ever complete by March 30 or at latest five days after that.

I am sure with all the swine flu noise DS are frantically trying to analyse and interpret the data, so a results announcement is imminent, but that is not what DS said.

I also comfortable that if the results are good, Biota will be able to strike a good deal.

I hope that makes my thoughts clear.

cheers
moreld